Brendan C. Bender, M.Sc., PhD

Senior Principal Scientist
Genentech, Inc

Poster(s):

• (S-117) Predicting Clinical Mosunetuzumab CD20 Receptor Occupancy using a Minimal Physiologically–Based Pharmacokinetic (mPBPK) Modeling Approach
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT